ctrl K

Price Alert

Fennec Pharmaceuticals In... (FENC)

NASDAQ: FENC · Real-Time Price · USD

8.14

-0.06 (-0.73%)

At close: Aug 19, 2025, 10:25 AM

Fennec Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	26.63M	13.27M	23.77M	21.1M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	822K	6K	211K	27K
Receivables	12.88M	8.81M	1.54M	n/a
Inventory	1.06M	2.16M	576K	n/a
Other Current Assets	466K	44K	63K	253K
Total Current Assets	44.12M	26.86M	26.73M	22.39M
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	822K	6K	211K	27K
Total Assets	44.95M	26.86M	26.94M	22.41M
Account Payables	2.88M	3.78M	2.39M	777K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	616K	n/a	n/a	n/a
Total Current Liabilities	6.92M	7.55M	4.61M	1.65M
Long-Term Debt	19.34M	30.93M	24.9M	4.99M
Other Long-Term Liabilities	24.56M	n/a	n/a	n/a
Total Long-Term Liabilities	43.9M	30.93M	24.9M	4.99M
Total Liabilities	50.82M	38.49M	29.51M	6.64M
Total Debt	19.34M	30.95M	24.9M	4.99M
Common Stock	145.61M	144.31M	142.59M	140.8M
Retained Earnings	-219.68M	-219.25M	-203.2M	-179.49M
Comprehensive Income	1.24M	1.24M	1.24M	1.24M
Shareholders Equity	-5.51M	-11.62M	-2.57M	15.77M
Total Investments	n/a	n/a	n/a	n/a